Skip To Main Content
Sydney Lupkin on Muck Rack

Sydney Lupkin

Verified
  • Pharmaceuticals Correspondent, NPR
Washington, D.C.
As seen in: NPR, CNN, MSN, HuffPost, Scribd, USA Today, ABC News, ABC NewsOne, All Things Considered, Goats & Soda, Here & Now Anytime and
Correspondent at @NPRScience. Past: @KFFHealthNews, @VICENews, @MedPageToday, @ABC // DM for Signal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sydney

Contact Sydney, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

¿Tu seguro médico dejó de cubrir los medicamentos para bajar de peso? Esto es lo que necesitas saber

|
By Sydney Lupkin Verified
| Times of San Diego Verified
Entre 2025 y 2026, los seguros de 12 millones de personas dejaron de cubrir Zepbound y los de otros 12 millones dejaron de cubrir Wegovy, otro GLP-1. Cuando el seguro médico de Deborah Finley dejó de cubrir Zepbound, se dio cuenta rápidamente de que recuperar esa cobertura no sería nada sencillo. Finley, de 50 años y residente de Lodi, California, trabaja como cuidadora profesional a domicilio.
Open in Who Shared Issue with article?

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

|
By Sydney Lupkin Verified
| WVXU-FM (Cincinnati, OH) Verified
For the latest stories on the science of healthy living, subscribe to NPR's Health newsletter. Health Secretary Robert F Kennedy Jr. has long questioned the value of mRNA vaccine technology. And soon the Food and Drug Administration will decide whether to approve a new kind of flu shot built on mRNA. How the agency rules on the experimental vaccine made by Moderna has big implications for the future of mRNA research.
Open in Who Shared View Duplicates (186) Issue with article?
See all 30,443 licensed articles (30,529 Total)